AIT Q1 2026 Earnings Narrow Profit Miss Amidst Steady Operational Performance Cibus Inc Q1 2026 Earnings Narrowing Losses Amid PreRevenue Phase Kiniksa Pharmaceuticals Q1 2026 Earnings EPS Surprises by 315 Despite Stock Decline WU Q1 2026 Earnings EPS Falls Short of Estimates Stock Dips ZVRA Q1 2026 Earnings Strong EPS Beat Driven by NonOperating Items QH Q4 2021 Earnings Staggering EPS Miss Exposes Deep Operational Challenges